News for hackers. Stuff that matters.
Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by toomanybeersies on Wednesday November 10, 2021 @06:09AM (#29173400)
> Do we know how many experienced which specific "serious adverse event"?

From the topline data [1]:

- 3 Suicidal behaviour

- 5 Self-injury

- 4 Suicidal ideation

- 1 Drug withdrawal (from codeine?)

- 1 Adjustment disorder with anxiety

- 1 Adjustment disorder with mixed anxiety and depressed mood

- 1 Hospitalisation

[1] https://compasspathways.com/knowledge-navigator/pdf/COMP001%...

There are no comments on this comment yet.